for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reuters Now

Mylan CEO defends EpiPen's price hikes

Posted

Amid heavy criticism, Mylan CEO Heather Bresch testified before the House Oversight and Government Reform Committee Wednesday, defending the sharp price hike for the company's allergy drug EpiPen.

Reuters Now

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up